Hong Kong (HSI) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Aug 12, 2025

Discover Hong Kong Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the HSI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.

45 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
8049
Jilin Province Huinan Changlong Bio-pharmacy
HK$2.10-0.5%69.4%HK$1.2bn/aPE5.8xn/a13.0%
2877
China Shineway Pharmaceutical Group
HK$8.290.4%2.2%HK$6.3bHK$8.68PE6.8xE8.5%12.4%
239
Pak Fah Yeow International
HK$2.451.7%4.7%HK$763.5mn/aPE9.7xn/a8.2%
2161
JBM (Healthcare)
HK$2.87-4.7%202.1%HK$2.3bHK$3.31PE11.8xE15.9%8.0%
2633
Jacobson Pharma
HK$1.46-12.0%151.7%HK$2.9bn/aPE9.7xn/a7.5%
3737
Zhongzhi Pharmaceutical Holdings
HK$0.820%-19.6%HK$708.2mn/aPE6.8xn/a6.1%
2005
SSY Group
HK$3.051.7%-20.6%HK$9.0bHK$5.11PE8.5xE8.7%5.7%
2348
Dawnrays Pharmaceutical (Holdings)
HK$1.381.5%23.2%HK$2.1bn/aPE3.4xn/a4.6%
6826
Shanghai Haohai Biological Technology
HK$29.440.8%3.7%HK$12.7bHK$42.64PE14.9xE12.9%4.5%
1681
Consun Pharmaceutical Group
HK$13.662.3%147.0%HK$11.3bHK$11.95PE11.4xE11.6%4.4%
3933
United Laboratories International Holdings
HK$15.223.5%77.0%HK$30.0bHK$17.08PE10.3xE2.6%4.0%
719
Shandong Xinhua Pharmaceutical
HK$7.900.1%44.7%HK$10.5bn/aPE11.3xS8.7%3.8%
3613
Beijing Tong Ren Tang Chinese Medicine
HK$9.241.2%5.7%HK$7.7bHK$11.15PE15.5xE13.1%3.8%
1666
Tong Ren Tang Technologies
HK$5.312.9%3.5%HK$6.8bHK$6.16PE11.9xE8.5%3.7%
8329
Shenzhen Neptunus Interlong Bio-technique
HK$0.160%11.4%HK$261.8mn/aPE9.6xn/a3.4%
512
Grand Pharmaceutical Group
HK$8.290.1%83.8%HK$29.0bHK$9.76PE11.8xE3.3%3.1%
950
Lee's Pharmaceutical Holdings
HK$1.934.3%56.9%HK$1.1bn/aPE12.2xn/a2.6%
1093
CSPC Pharmaceutical Group
HK$10.726.6%82.6%HK$122.6bHK$9.61PE26.7xE6.8%2.4%
1061
Essex Bio-Technology
HK$5.43-2.0%127.2%HK$3.1bHK$6.84PE10xE12.0%2.2%
3320
China Resources Pharmaceutical Group
HK$5.320.8%-5.7%HK$33.4bHK$6.78PE9.2xE9.3%2.1%
867
China Medical System Holdings
HK$13.764.3%107.9%HK$33.3bHK$12.61PE18.8xE11.9%2.1%
690
Uni-Bio Science Group
HK$0.167.6%183.6%HK$931.5mn/aPE11.3xn/a1.8%
1349
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$3.92-6.4%114.2%HK$9.5bn/aPE92.7xn/a1.7%
2096
Simcere Pharmaceutical Group
HK$12.66-0.8%136.6%HK$31.3bHK$13.64PE39.1xE22.9%1.4%
Page 1 of 2